Breaking News Instant updates and real-time market news.

WFC

Wells Fargo

$43.78

-0.5034 (-1.14%)

, MYL

Mylan

$38.12

-0.35 (-0.91%)

12:43
10/03/16
10/03
12:43
10/03/16
12:43

Clinton to mention Mylan, Wells Fargo as 'bad corporate actors,' Reuters says

While campaigning in Ohio on Monday, U.S. presidential candidate Hillary Clinton is expected to disclose a plan to make it easier for consumers to take legal action against "bad corporate actors," citing companies Wells Fargo (WFC) and Mylan (MYL) says Reuters, citing a campaign official. Reference Link

WFC

Wells Fargo

$43.78

-0.5034 (-1.14%)

MYL

Mylan

$38.12

-0.35 (-0.91%)

  • 07

    Oct

  • 23

    Oct

  • 28

    Mar

WFC Wells Fargo
$43.78

-0.5034 (-1.14%)

09/21/16
JPMS
09/21/16
DOWNGRADE
Target $48
JPMS
Neutral
Wells Fargo downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Vivek Juneja downgraded Wells Fargo to Neutral saying the "tough" Senate hearings and "mounting public scrutiny" will likely result in additional investigations that could pressure expenses. There is "significant uncertainty about how much some issues will cost and how long they will take," Juneja tells investors in a research note. He believes Wells will need to spend a lot more on litigation and that its revenues "will likely face some slowdown in growth." Juneja cut his price target for the shares to $48 from $53.50. Wells Fargo closed yesterday up 55c to $46.56.
09/21/16
09/21/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Neutral from Overweight at JPMorgan with analyst Vivek Juneja saying the "tough" Senate hearings and "mounting public scrutiny" will likely result in additional investigations that could pressure expenses. 2. Skechers (SKX) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Jay Sole saying he believes consumers shift towards pure fashion styles and away from athletic footwear is causing Skechers to adjust assortment, resulting in slower sales growth. 3. American Airlines (AAL) downgraded to Market Perform from Outperform at Raymond James analyst Savanthi Syth citing relative valuation and lowered estimates to reflect the new mechanics contract. 4. Boston Beer (SAM) downgraded to Underperform from Market Perform at Cowen with analyst Vivien Azer citing its string of disappointing monthly Nielsen data and structural headwinds to the company's core assets, which present meaningful earnings risk. 5. Children's Place (PLCE) downgraded to Neutral from Overweight at Piper Jaffray with analyst Stephanie Wissink saying the firm's recent survey of moms pointed to a "step down" in mindshare. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/22/16
DBAB
09/22/16
NO CHANGE
Target $50
DBAB
Buy
Wells Fargo price target lowered to $50 from $59 at Deutsche Bank
Deutsche Bank analyst Matt O'Connor lowered his price target for Wells Fargo to $50 saying it's "tough to argue for much upside in the near term." The analyst, however, believes that over the next year, Wells Fargo's issues should subside and its "attractive valuation should be more relevant." After laying out the bull and bear thesis on the shares, O'Connor sees 5%-12% relative upside in the name. He keeps a Buy rating on Wells Fargo.
09/28/16
DBAB
09/28/16
UPGRADE
Target $11.5
DBAB
Buy
Huntington Bancshares upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Matt O'Connor upgraded Huntington Bancshares to Buy saying the 15% pullback in the shares since the FirstMerit (FMER) deal was announced is overdone. The analyst views industry-wide concerns surrounding consumer indirect auto lending as overblown and he raised his price target for Huntington shares to $11.50 from $10.50. Going into the Q3 results for U.S. banks, O'Connor likes JPMorgan (JPM) and Wells Fargo (WFC) and is cautious on Fifth Third (FITB).
MYL Mylan
$38.12

-0.35 (-0.91%)

09/22/16
LEER
09/22/16
NO CHANGE
LEER
Outperform
No tangible outcomes likely to result from Mylan EpiPen hearing, says Leerink
Leerink analyst Jason Gerberry believes no tangible outcomes are likely to result from the House Committee Hearing on Mylan's EpiPen. Nonetheless, the analyst highlights that CEO Heather Bresch stated at the hearing that the company has invested in a new formulation of EpiPen, with a 24-month shelf life versus the current 12-month. Gerberry believes this is a relatively modest benefit and says he is skeptical the line extension will be able to preserve meaningful share if/when an AB-rated generic gets approved. The analyst reiterates an Outperform rating on the shares.
09/22/16
ARGS
09/22/16
NO CHANGE
ARGS
Mylan weakness creates good entry point, says Argus
After Mylan's stock fell 17% over the last month, Argus analyst Jacob Kilstein thinks that the stock has reached an attractive entry point, He says that the company's new generic EpiPen will cannibalize branded sales but should help it beat upcoming generic competitors. He thinks that the stock is undervalued and keeps a Buy rating on the stock.
09/23/16
BERN
09/23/16
NO CHANGE
BERN
Mylan generic Epipen to lower EPS by about 10%, says Bernstein
Bernstein analyst Aaron Gal estimates that Mylan's decision to introduce a generic version of its EpiPen will create a drag of about 10% on its EPS. After viewing the Congressional hearings on the device, Gal continues to believe that a competitor to EpiPen will hit the market before the end of 2018. He keeps a $60 price target and Outperform rating on Mylan.
09/30/16
LEER
09/30/16
NO CHANGE
Target $45
LEER
Outperform
Mylan price target cut to $45 on lower EpiPen estimates at Leerink
Leerink analyst Jason Gerberry lowered his EpiPen sales forecasts by 33-45% from 2017-2021 in light of recent company updates, including its plan to launch an authorized generic of the emergency treatment later this year. While Mylan "appears on the right side of the law" regarding the latest Medicaid rebate controversy, Gerberry believes investors should consider the risk of a future settlement related to the issue. He cut his price target on Mylan shares to $45 from $55, but keeps an Outperform rating on the stock as he sees cash flows being sufficient to justify the current price.

TODAY'S FREE FLY STORIES

MSTX

Mast Therapeutics

$0.14

0.003 (2.22%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Mast Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

MTSI

MACOM

$50.32

-3.52 (-6.54%)

, SBGI

Sinclair Broadcast

$40.35

1.05 (2.67%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
National Association of Broadcasters to hold a conference »

NAB Show 2017 is being…

MTSI

MACOM

$50.32

-3.52 (-6.54%)

SBGI

Sinclair Broadcast

$40.35

1.05 (2.67%)

NXST

Nexstar

$69.90

1 (1.45%)

TRCO

Tribune Media

$36.72

0.17 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 09

    May

  • 22

    May

  • 23

    May

CLLS

Cellectis

$23.83

0.26 (1.10%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Cellectis management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 28

    Apr

  • 03

    May

  • 06

    Jun

RDHL

RedHill Biopharma

$10.29

0.0199 (0.19%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
RedHill Biopharma to host research and development day »

Research &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

RXDX

Ignyta

$9.20

0.25 (2.79%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Ignyta holds a conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 06

    Jun

BGG

Briggs & Stratton

$25.14

0.09 (0.36%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Briggs & Stratton management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 10

    May

GTN

Gray Television

$15.05

0.4 (2.73%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Gray Television management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 28

    Apr

  • 03

    May

  • 04

    May

SGM

Stonegate Mortgage

$7.96

-0.0059 (-0.07%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Stonegate Mortgage to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Breaking General news story  »

Week of 4/21 EIA Natural…

CMRX

Chimerix

$6.09

-0.01 (-0.16%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Chimerix to hold an investor update webcast »

Chief Medical Officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Pending Home Sales Index to be reported at 10:00 »

March Pending Home Sales…

RGLS

Regulus

$1.55

0.1 (6.90%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Regulus management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Berenberg to hold a conference »

U.K. Corporate Conference…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
The Food & Drug Law Institute to hold a conference »

Introduction to U.S. Drug…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 4/22 Jobless…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Breaking General news story  »

Week of 4/23 Bloomberg…

LGF

Use LGF.A, LGF.B

, AMCX

AMC Networks

$60.25

0.65 (1.09%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
FBN Securities media/cable analyst holds an analyst/industry conference call »

Media. Cable &…

LGF

Use LGF.A, LGF.B

AMCX

AMC Networks

$60.25

0.65 (1.09%)

DISCA

Discovery

$29.39

0.1 (0.34%)

CBS

CBS

$66.91

0.5 (0.75%)

NFLX

Netflix

$150.17

-1.99 (-1.31%)

AMZN

Amazon.com

$909.29

1.67 (0.18%)

VIA.B

Symbol now VIAB

NLSN

Nielsen

$39.41

-0.57 (-1.43%)

SNI

Scripps Networks

$76.49

0.53 (0.70%)

TWX

Time Warner

$100.20

0.16 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 04

    May

  • 04

    May

  • 08

    May

  • 16

    May

  • 16

    May

  • 18

    May

  • 18

    May

  • 23

    May

  • 31

    May

  • 05

    Jun

  • 15

    Jun

MEOH

Methanex

$46.10

0.15 (0.33%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Methanex Corporation to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Durable Goods Orders Ex-transportation to be reported at 08:30 »

March Durable Goods…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Durable Goods Orders to be reported at 08:30 »

March Durable Goods…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Breaking General news story  »

Week of 4/26 Fed Balance…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Breaking General news story  »

Week of 4/17 Money Supply…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Breaking General news story  »

3-Month Bill Announcement…

WWD

Woodward

$68.05

-0.11 (-0.16%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Woodward management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 28

    Apr

  • 09

    May

  • 11

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.